| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Amenta F, Chiandussi L, Mancini M, Ricci A, Schena M, Veglio F. Pharmacological characterization and autoradiographic localization of dopamine receptors in the human adrenal cortex. Eur J Endocrinol 1994;131:91–6. ISSN 0804–4643
The pharmacological characteristics and the anatomical localization of dopamine D1-like and D2-like receptors were studied in sections of the human adrenal cortex using radioligand binding and autoradiographic techniques. [3H]SCH23390 was used as a ligand of D1-like receptors, whereas [3H]spiroperidol was used to label D2-like receptors. No specific [3H]SCH 23390 binding was detectable in sections of the human adrenal cortex. On the other hand, [3H]spiroperidol was bound to sections of the adrenal gland in a manner consistent with the labelling of dopamine D2-like receptor sites. The binding was time, temperature and concentration dependent, belonging in the range of concentrations of the radioligand used for a single class of high-affinity sites. The dissociation constant (Kd) averaged 2.7 nmol/l, whereas the maximum density of binding sites (Bmax) was 160 nmol/mg tissue. Experiments on the pharmacological specificity of [3H]spiroperidol binding to sections of the human adrenal cortex revealed that clozapine was the most powerful displacer of [3H]spiroperidol from sections of the human adrenal cortex. This suggests the presence in the human adrenal cortex of dopamine receptors of the D4 subtype. Light microscope autoradiography showed the highest density of specific [3H]spiroperidol binding sites in the zona glomerulosa and to a lesser extent in the zona reticularis. Only sparse [3H]spiroperidol binding sites were localized in the zona fasciculata. The possible functional consequences of this localization of dopamine D2-like receptor sites in the human adrenal cortex are discussed.
Francesco Amenta, Istituto di Farmacologia, Via Scalzino 5, 62032 Camerino, Italy
This article has been cited by other articles:
|
|
 |
|
  R. Pivonello, D. Ferone, G. Lombardi, A. Colao, S. W J Lamberts, and L. J Hofland Novel insights in dopamine receptor physiology Eur. J. Endocrinol., April 1, 2007; 156(suppl_1): S13 - S21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ahmadzadeh, M. A. Barnes, F. C. Gwazdauskas, and R. M. Akers Dopamine antagonist alters serum cortisol and prolactin secretion in lactating Holstein cows. J Dairy Sci, June 1, 2006; 89(6): 2051 - 2055. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Pivonello, D. Ferone, W. W. de Herder, R. R. de Krijger, M. Waaijers, D. M. Mooij, P. M. van Koetsveld, A. Barreca, M. L. Del Basso De Caro, G. Lombardi, et al. Dopamine Receptor Expression and Function in Human Normal Adrenal Gland and Adrenal Tumors J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4493 - 4502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-D. Wu, Y.-M. Chen, T.-S. Chu, S.-C. Chueh, M.-H. Wu, and H. Bor-Shen Expression and Localization of Human Dopamine D2 and D4 Receptor mRNA in the Adrenal Gland, Aldosterone-Producing Adenoma, and Pheochromocytoma J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4460 - 4467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. MISSALE, S. R. NASH, S. W. ROBINSON, M. JABER, and M. G. CARON Dopamine Receptors: From Structure to Function Physiol Rev, January 1, 1998; 78(1): 189 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Aherne, C. J. Vaughan, R. M. Carey, and D. P. O'Connell Localization of Dopamine D1A Receptor Protein and Messenger Ribonucleic Acid in Rat Adrenal Cortex Endocrinology, March 1, 1997; 138(3): 1282 - 1288. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
